ACTIVE HALF-LIFE
2-3 days
CLASSIFICATION
Non-steroidal aromatase inhibitor
DOSAGE
0.5-1 mg throughout 1 to 3 days
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Hilma Biocare
LAB TEST
See Document
WAREHOUSE
EU Warehouse 3
SUBSTANCE
Letrozole
,
Letrozole is an antitumor medication that acts as a non-steroidal selective aromatase inhibitor. It is commonly prescribed in the treatment of breast cancer and as part of post-menopausal therapy for women. Among athletes, it has gained popularity for its potent anti-estrogenic effects and ability to enhance muscle definition. Compared to Anastrozole (Arimidex), Letrozole is up to five times more powerful in mitigating negative side effects associated with anabolic steroid usage. It effectively reduces estrogen levels in the body, offering significant protection against elevated estradiol.
Athletes who use Letrozole can significantly lower their body's estrogen levels and guard against aromatization.
Effects:Common side effects related to Letrozole include skin rashes, nausea, abdominal discomfort, fatigue, dizziness, headaches, elevated low-density cholesterol levels, and increased liver enzymes.
Side Effects:It is advisable to conduct preliminary blood tests before starting Letrozole. This can lead to a substantial decrease in estradiol levels and enhance the overall effectiveness of your cycle. Letrozole functions as an anti-estrogenic agent and is often utilized during post-cycle therapy (PCT).
Protection:While Letrozole is particularly effective during PCT, it can also be combined with clomiphene or other steroids as part of a cycle.
Stacking: